Long-term treatment of Swiss 3T3 fibroblasts with dexamethasone attenuates MAP kinase activation induced by insulin-like growth factor-I (IGF-I). (Q42812804)
scientific article published on June 1996
Language:
Current Data About Long-term treatment of Swiss 3T3 fibroblasts with dexamethasone attenuates MAP kinase activation induced by insulin-like growth factor-I (IGF-I).
(P31) (Q13442814)
(P248)
(P698) 8640952
(P813) Tuesday, November 7, 2017

(P304) 121-129
(P248)
(P698) 8640952
(P813) Tuesday, November 7, 2017

(P433) 2
(P248)
(P698) 8640952
(P813) Tuesday, November 7, 2017

(P478) 14
(P248)
(P698) 8640952
(P813) Tuesday, November 7, 2017

(P577) Saturday, June 1, 1996
(P248)
(P698) 8640952
(P813) Tuesday, November 7, 2017

(P921) (Q422252)
(P887)

(P1433) (Q5058145)
(P248)
(P698) 8640952
(P813) Tuesday, November 7, 2017

(P1476) "Long-term treatment of Swiss 3T3 fibroblasts with dexamethasone attenuates MAP kinase activation induced by insulin-like growth factor-I (IGF-I)." (language: en)
(P248)
(P698) 8640952
(P813) Tuesday, November 7, 2017

(P2093) Hansson A
(P1545) 1
(P248)
(P698) 8640952
(P813) Tuesday, November 7, 2017

Hehenberger K
(P1545) 2
(P248)
(P698) 8640952
(P813) Tuesday, November 7, 2017

Thorén M
(P1545) 3
(P248)
(P698) 8640952
(P813) Tuesday, November 7, 2017

other details
description scientific article published on June 1996

External Links
(P356) 10.1002/(SICI)1099-0844(199606)14:2<121::AID-CBF656>3.0.CO;2-Q
(P698) 8640952